These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

716 related items for PubMed ID: 30384060

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pyropia yezoensis protein protects against TNF‑α‑induced myotube atrophy in C2C12 myotubes via the NF‑κB signaling pathway.
    Lee MK, Choi YH, Nam TJ.
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33955507
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. PI3 kinase regulation of skeletal muscle hypertrophy and atrophy.
    Glass DJ.
    Curr Top Microbiol Immunol; 2010 Jul; 346():267-78. PubMed ID: 20593312
    [Abstract] [Full Text] [Related]

  • 8. A novel in vitro model for the assessment of postnatal myonuclear accretion.
    Kneppers A, Verdijk L, de Theije C, Corten M, Gielen E, van Loon L, Schols A, Langen R.
    Skelet Muscle; 2018 Feb 14; 8(1):4. PubMed ID: 29444710
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
    Castillero E, Alamdari N, Lecker SH, Hasselgren PO.
    Metabolism; 2013 Oct 14; 62(10):1495-502. PubMed ID: 23866982
    [Abstract] [Full Text] [Related]

  • 11. Muscle-specific overexpression of the type 1 IGF receptor results in myoblast-independent muscle hypertrophy via PI3K, and not calcineurin, signaling.
    Quinn LS, Anderson BG, Plymate SR.
    Am J Physiol Endocrinol Metab; 2007 Dec 14; 293(6):E1538-51. PubMed ID: 17940216
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of type IV collagen on myogenic characteristics of IGF-I gene-engineered myoblasts.
    Ito A, Yamamoto M, Ikeda K, Sato M, Kawabe Y, Kamihira M.
    J Biosci Bioeng; 2015 May 14; 119(5):596-603. PubMed ID: 25454061
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Promotion of myotube differentiation and attenuation of muscle atrophy in murine C2C12 myoblast cells treated with teaghrelin.
    Hsieh SK, Lin HY, Chen CJ, Jhuo CF, Liao KY, Chen WY, Tzen JTC.
    Chem Biol Interact; 2020 Jan 05; 315():108893. PubMed ID: 31706954
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [A Cellular Pharmacological Approach to the Development of Drugs to Treat Muscle Wasting].
    Sakamoto K.
    Yakugaku Zasshi; 2018 Jan 05; 138(10):1271-1275. PubMed ID: 30270271
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.